tradmap

TXN Financials Texas Instruments

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 4.1% per year over the past 5 years.
  • Net income has grown slower than revenue (-2.2% vs 4.1% per year).
  • Operating margin has contracted, at 34.1% in the latest year.
  • Free cash flow has declined 13.9% per year over the past 5 years.

Financial health

  • Total debt ($14.0B) exceeds cash ($3.2B); net debt is $10.8B.
  • Total debt has grown faster than revenue (15.6% vs 4.1% per year).
  • Operating income covered interest expense 11× in the latest year, down from 31× 5 years ago.
  • Total debt is 2.3× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 100.0% of earnings and 192.0% of free cash flow.
  • The dividend has grown 7.8% per year over the past 5 years.
Revenue & net income
$0 $10B $20B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 34% 69% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $3B $6B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $7B $14B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$7B $1B $9B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $17.7B $5.0B 57.0% 34.1% $2.6B $14.0B $3.2B
2024 $15.6B $4.8B 58.1% 34.9% $1.5B $13.6B $3.2B
2023 $17.5B $6.5B 62.9% 41.8% $1.3B $11.2B $3.0B
2022 $20.0B $8.7B 68.8% 50.6% $5.9B $8.7B $3.0B
2021 $18.3B $7.8B 67.5% 48.8% $6.3B $7.7B $4.6B
2020 $14.5B $5.6B 64.1% 40.8% $5.5B $6.8B $3.1B
2019 $14.4B $5.0B 63.7% 39.8% $5.8B $5.8B $2.4B
2018 $15.8B $5.6B 65.1% 42.5% $6.1B $5.1B $2.4B
2017 $15.0B $3.7B 64.3% 40.7% $4.7B $4.1B $1.7B
2016 $13.4B $3.6B 61.8% 36.3% $4.1B $3.6B $1.2B
2015 $3.0B $4.1B $1.0B
2014 $2.8B $4.6B $1.2B
2013 $2.2B $5.2B $1.6B
2012 $1.8B $4.2B $1.4B
2011 $2.2B $5.2B $992M

Valuation over time

How the market has priced TXN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 28.4 56.7 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 8.0 16.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.7 3.3 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is TXN growing its revenue and profit?

Over the past 5 years, Texas Instruments's revenue has grown 4.1% per year, and net income declined 2.2% per year. These are computed facts, not advice.

How much debt does TXN have?

As of FY2025, Texas Instruments reported $14.0B of total debt against $3.2B of cash; operating income covered interest expense 11×.

What is TXN's profit margin?

In FY2025, gross margin was 57.0%, operating margin 34.1%, and net margin 28.3%.

What is TXN's P/E ratio?

As of Jun '26, Texas Instruments traded at a price-to-earnings ratio of about 56.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.